OpenAI Researcher to Launch Drug Discovery Startup
TechCrunch AI · rss · 2026-07-15
TechCrunch AI reports that OpenAI researcher Miles Wang is raising funds for an AI drug discovery startup, targeting a valuation of around $2 billion.
The report also notes that Lightspeed is in talks to lead the funding round; however, negotiations are ongoing, making this an unconfirmed deal rumor.
More from Venture
- Revolut CEO Nik Storonsky: China's 9/9/6 workers out-compete US and Europe — davidsenra · 2026-10-27
- He gave his AI agent a phone number and email — then hired it as social media manager — heyshrutimishra · 2026-10-27
- Firecrawl launches Alexandria company-data API and announces $75M Series B — devdigest · 2026-10-27
- Anthropic files for IPO: $16.3B H1 revenue, up from $1.2B a year earlier — RebeccaBellan · 2026-10-27
- Anthropic S-1: Over half of $100K+ customers now use both Claude platform and first-party apps — RebeccaBellan · 2026-10-27
- Codex clones Linear's core from a one-page spec in 3 minutes 28 seconds — aakashgupta · 2026-10-27